A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/02/2011	EP2382981A2 Use of Core 2 GlcNac-T inhibitors III for the treatment of inflammatory conditions
11/02/2011	EP2382980A2 Use of Core 2 GlcNac-T inhibitors III for treating vascular complications of diabetes
11/02/2011	EP2382979A2 Use of core 2 GlcNac-T inhibitors III for treating autoimmune diseases
11/02/2011	EP2382978A2 Modulation of the immune system by inositol phospholipids
11/02/2011	EP2382977A1 Therapeutic agents targeting the ncca-atp channel and methods of use thereof
11/02/2011	EP2382976A1 Use of pdgf-r inhibitors for the treatment of lymph node metastasis of gastric cancer
11/02/2011	EP2382975A2 Neurogenesis by modulating angiotensin
11/02/2011	EP2382974A1 Use of cyclosquaramide compounds as anti-tumour agents
11/02/2011	EP2382973A1 Composition of rectal suppositories based on natural extracts for the soothing and emollient treatment of the anorectal canal.
11/02/2011	EP2382972A1 Methods for preventing and treating neurodegenerative disorders
11/02/2011	EP2382970A1 Stable Pharmaceutical Compositions Containing 7-Substituted-3,5-Dihydroxyheptanoic Acids or 7-Substituted-3,5-Dihydroxyheptenoic Acids
11/02/2011	EP2382969A1 Multicoated Aliskiren formulations
11/02/2011	EP2382968A1 Particle size distribution of fusidic acid granules
11/02/2011	EP2382967A1 Aliskiren in the form of a solid dispersion
11/02/2011	EP2382874A1 Amino acid supplementation for a healthy microbiota ecosystem
11/02/2011	EP2382873A1 Novel use of organic compound
11/02/2011	EP2382223A1 Phenylalkyl-imidazole-bisphosphonate compounds
11/02/2011	EP2382219A1 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
11/02/2011	EP2382218A1 Delta-5-desaturase inhibitors
11/02/2011	EP2382215A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
11/02/2011	EP2382214A1 Method of preparing (+)-1,4-dihydro-7-ý(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl¨-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
11/02/2011	EP2382213A1 One-step process for preparing paliperidone and its oxalate salt
11/02/2011	EP2382212A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
11/02/2011	EP2382211A1 Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists
11/02/2011	EP2382210A2 Pyrimidinediamine kinase inhibitors
11/02/2011	EP2382209A1 Polymorphic form of 5-chloro-n-{ý(5s)-2-oxo-3-ý4-(3-oxomorpholin-4-yl)phenyl¨oxa-zolidin-5-yl¨-methyl}thiophene-2-carboxamide
11/02/2011	EP2382207A2 Pi3k/mtor kinase inhibitors
11/02/2011	EP2382206A2 Compounds and methods for the treatment of pain and other diseases
11/02/2011	EP2382205A2 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
11/02/2011	EP2382204A1 Pyrimidine derivatives as gpcr modttlators for use in the treatment of obesity and diabetes
11/02/2011	EP2382203A1 Bicyclic heterocycle derivatives and methods of use thereof
11/02/2011	EP2382202A1 Dihydropyridone amides as p2x7 modulators
11/02/2011	EP2382201A1 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
11/02/2011	EP2382200A1 Competitive inhibitors of type ii dehydroquinase enzyme
11/02/2011	EP2382197A1 Modulators of cystic fibrosis transmembrane conductance regulator
11/02/2011	EP2382194A2 Compounds for the prevention and treatment of cardiovascular disease
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2382192A2 Dihydropyridone amides useful as medicaments for the treatment of autoimmune and inflammatory diseases
11/02/2011	EP2382191A1 Novel benzenesulfonamides as calcium channel blockers
11/02/2011	EP2382190A1 Toluidine sulfonamides and their use as-inhibitors
11/02/2011	EP2382189A1 Toluidine sulfonamides and their use
11/02/2011	EP2382014A1 Long wear lip product
11/02/2011	EP2382013A1 Selective histamine h4 receptor antagonists for the treatment of vestibular disorders.
11/02/2011	EP2382012A2 Pharmaceutical compounds
11/02/2011	EP2381962A1 Composition for prolonged release of heparin and use of the alginate-hydroxypropylcellulose gel for prolonged release of heparin
11/02/2011	EP2381961A1 Implantable devices for treating hiv
11/02/2011	EP2381957A2 Therapeutic modulation of vaginal epithelium boundary lubrication
11/02/2011	EP2381956A1 Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
11/02/2011	EP2381955A1 Combination therapies using nap
11/02/2011	EP2381951A2 Compositions and methods of treating viral infections
11/02/2011	EP2381950A2 Compositions and methods of use
11/02/2011	EP2381949A1 Immunostimulating saponins for use in in situ tumor-destruction therapy
11/02/2011	EP2381948A2 Compounds and methods for enhancing erythropoiesis
11/02/2011	EP2381947A1 Mass spectrometry assay for estrogenic compounds
11/02/2011	EP2381946A1 Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
11/02/2011	EP2381945A2 Topical formulations of flap inhibitors for the treatment of dermatological conditions
11/02/2011	EP2381944A1 Anti-viral compounds, treatment, and assay
11/02/2011	EP2381943A1 Substituted quinazoline compounds
11/02/2011	EP2381942A1 Combination therapies for neoplastic disorders
11/02/2011	EP2381941A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
11/02/2011	EP2381940A2 A new family of pain producing substances and methods to produce novel analgesic drugs
11/02/2011	EP2381939A1 Cosmetic composition containing ketogluconic acid derivatives
11/02/2011	EP2381938A1 Maintenance fluid for animals
11/02/2011	EP2381937A2 Opioid-containing oral pharmaceutical compositions and methods
11/02/2011	EP2381936A1 Pathways to generate hair cells
11/02/2011	EP2381935A1 Synergistic combinations of carotenoids and polyphenols
11/02/2011	EP2381934A2 Improving cognitive function
11/02/2011	EP2381927A1 Pharmaceutical formulation of nanonised fenofibrate
11/02/2011	EP2381924A1 Method for adding sensory conditioning cues in a pharmacotherapeutic regimen
11/02/2011	EP2381923A2 Safe desmopressin administration
11/02/2011	EP2381917A1 Moisturizing mixture, cosmetic and/or pharmaceutical compositions containing the moisturizing mixture, use of the moisturizing mixture, and cosmetic method
11/02/2011	EP2381797A1 Animal feed additive and animal feed comprising alkyl esters of medium chain fatty acids, and their use in animal feed
11/02/2011	EP2381786A1 Polymorphs of darunavir
11/02/2011	EP2381784A1 Nutritional intervention for improving muscular function and strength
11/02/2011	EP2381783A1 Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits
11/02/2011	EP2381780A1 Compositions comprising decitabine and tetrahydrouridine and uses thereof
11/02/2011	EP2381779A1 Selective inhibitors of akt and methods of using same
11/02/2011	EP2381778A1 C5ar antagonists
11/02/2011	EP2381777A1 Azaindole derivatives as kinase inhibitors
11/02/2011	EP2381775A1 Small molecule inhibitors of necroptosis
11/02/2011	EP2381773A1 Compositions for drug administration
11/02/2011	EP2381767A1 Delayed release rasagiline formulation
11/02/2011	EP2294068B1 1,3-dihydro-2h-pyrrolo[3,2-b]pyridin-2-one derivatives, preparation thereof and therapeutic uses thereof
11/02/2011	EP2294063B1 Pyrrolidine ether derivatives as nk3 receptor antagonists
11/02/2011	EP2283008B1 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/02/2011	EP2278977B1 Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors
11/02/2011	EP2278973B1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
11/02/2011	EP2245014B1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/02/2011	EP2238115B1 Novel imidazolinylmethyl aryl sulfonamides
11/02/2011	EP2222668B1 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
11/02/2011	EP2203458B1 Cyanoaminoquinolones as gsk-3 inhibitors
11/02/2011	EP2185550B1 Substituted aryloxazoles and the use thereof
11/02/2011	EP2114931B1 Piperidine gpcr agonists
11/02/2011	EP2069354B1 Aza-benzofuranyl compounds and methods of use
11/02/2011	EP2059234B1 Method for reducing or alleviating inflammation in the digestive tract
11/02/2011	EP2051710B1 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
11/02/2011	EP2046310B1 Treatment and prevention of excessive scarring
11/02/2011	EP2013183B1 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the beta2 adrenergic receptor
11/02/2011	EP2007767B1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors
11/02/2011	EP1994019B1 Novel piperidin - substituted indoles and their use as ccr-3 modulators

1 ... 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 ... 7860